NIS Labs   Report issue

For profit Phase 4
Founded: Klamath Falls OR United States (1999)

Organization Overview

First Clinical Trial
2012
NCT02886507
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

NIS Labs

Active Ingredients

Drugs in Phase 4 Trials (1)

nattokinase (1 trial)

Drugs in Other Trials (4)

black tea extract (1 trial)

curcumin (1 trial)

ergothioneine (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 5